GALECTIN THERAPEUTICS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $43.9M | $47.5M |
| FY2020 | — | $22.5M | $27.1M |
| FY2021 | — | $893.0K | $39.6M |
| FY2022 | — | $-33.9M | $18.6M |
| FY2023 | — | $-62.0M | $25.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $43.9M | $47.5M |
| FY2020 | — | $22.5M | $27.1M |
| FY2021 | — | $893.0K | $39.6M |
| FY2022 | — | $-33.9M | $18.6M |
| FY2023 | — | $-62.0M | $25.7M |